Atipamezole
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATCvet code | QV03AB90 (WHO) |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | 104054-27-5 |
PubChem (CID) | 71310 |
ChemSpider | 64427 |
UNII | 03N9U5JAF6 |
KEGG | D03002 |
ChEMBL | CHEMBL353972 |
Chemical and physical data | |
Formula | C14H16N2 |
Molar mass | 212.290 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Atipamezole (brand name Antisedan, Pfizer) is a synthetic α2 adrenergic receptor antagonist, indicated for the reversal of the sedative and analgesic effects of dexmedetomidine and medetomidine in dogs.[1]
It has also been researched in humans as a potential anti-Parkinsonian drug.[2]
Dosing
In a study using New Zealand white rabbits, the optimal dose for revival of sedation by a medetomidine-ketamine mixture was found to be equal to or double the dose of medetomidine.[3]
See also
- Detomidine, etc.
References
- ↑ Pfizer Animal Health ANTISEDAN Product Overview Archived June 17, 2008, at the Wayback Machine.
- ↑ Pertovaara A, Haapalinna A, Sirviö J, Virtanen R (2005). "Pharmacological properties, central nervous system effects, and potential therapeutic applications of atipamezole, a selective alpha2-adrenoceptor antagonist". CNS Drug Reviews. 11 (3): 273–88. doi:10.1111/j.1527-3458.2005.tb00047.x. PMID 16389294.
- ↑ Kim MS; et al. (2004). "Reversal of Medetomidine-Ketamine Combination Anesthesia in Rabbits by Atipamezole". Experimental Animals. 53 (5): 423–428. doi:10.1538/expanim.53.423.
External links
This article is issued from Wikipedia - version of the 11/14/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.